Ursodeoxycholic acid (UDCA) may be of use in treatment of patients with chronic hepatitis C virus (HCV) who do not respond to therapy with combined pegylated interferon and ribavirin, Japanese researchers report in the December issue of Gut. Reuters Health Information
Peginterferon alfa-2b and ribavirin therapy is no longer restricted to treatment-naive patients and may be used to treat chronic hepatitis C virus infection in patients with compensated liver disease. Medscape Medical News
Unsedated colonoscopy is better tolerated when water is infused than when air is insufflated, according to a report in the July 8th Gastrointestinal Endoscopy online. Reuters Health Information
Commentary on a study on whether single-port laparoscopic cholecystectomy is superior to the standard multiport approach, published July 2011 in the Annals of Surgery. Medscape General Surgery
